First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial
| Autor: | Baas, Paul *, Scherpereel, Arnaud, Nowak, Anna K, Fujimoto, Nobukazu, Peters, Solange, Tsao, Anne S, Mansfield, Aaron S, Popat, Sanjay, Jahan, Thierry, Antonia, Scott, Oulkhouir, Youssef, Bautista, Yolanda, Cornelissen, Robin, Greillier, Laurent, Grossi, Francesco, Kowalski, Dariusz, Rodríguez-Cid, Jerónimo, Aanur, Praveen, Oukessou, Abderrahim, Baudelet, Christine, Zalcman, Gérard |
|---|---|
| Zdroj: | In The Lancet 30 January-5 February 2021 397(10272):375-386 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|